Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	443	716	522	645	1,207	3,704
Market Cap Growth	-7.06%	37.10%	-19.13%	-46.51%	-67.42%	78.05%
Enterprise Value	1,029	1,262	1,017	1,090	1,623	4,137
Last Close Price	0.16	0.26	0.19	0.23	0.43	1.32
PE Ratio	38.54	26.70	-	-	-	-
PS Ratio	6.62	10.68	3.26	3.25	3.82	13.07
PB Ratio	16.19	26.12	-12.84	30.63	4.26	7.61
P/TBV Ratio	-	-	-	-	4.58	7.89
P/OCF Ratio	-	-	-	295.63	-	-
EV/Sales Ratio	15.37	18.84	6.36	5.49	5.14	14.59
Debt / Equity Ratio	18.72	18.72	-11.85	22.75	1.73	0.85
Net Debt / Equity Ratio	18.53	18.53	-10.04	20.68	1.20	0.64
Net Debt / EBITDA Ratio	-10.84	-10.84	-12.24	-6.10	-11.24	-9.04
Net Debt / FCF Ratio	-	-	-7.63	-29.15	-8.65	-1.43
Asset Turnover	0.11	0.11	0.28	0.27	0.33	0.28
Inventory Turnover	2.37	2.37	4.41	5.69	5.72	5.31
Quick Ratio	0.03	0.03	0.22	0.26	0.53	0.36
Current Ratio	0.17	0.17	0.31	0.43	0.79	0.51
Return on Equity (ROE)	-	-	-	-178.98%	-52.60%	-23.76%
Return on Assets (ROA)	-6.43%	-6.43%	-5.04%	-7.54%	-2.77%	-2.39%
Return on Invested Capital (ROIC)	-11.24%	-13.32%	-11.32%	-16.69%	-5.97%	-5.39%
Return on Capital Employed (ROCE)	-212.90%	-212.90%	608.80%	-39.80%	-8.90%	-7.70%
Earnings Yield	6.04%	3.74%	-16.88%	-41.67%	-16.42%	-1.97%
FCF Yield	-	-	-10.26%	-2.32%	-3.26%	-5.87%
Buyback Yield / Dilution	-0.09%	-0.09%	-	-	-0.39%	-4.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.